FDA kicks off review of CBD with 140 people scheduled to testify at first public hearing Friday - CNBC

1. FDA kicks off review of CBD with 140 people scheduled to testify at first public hearing Friday  CNBC
2. CBD Industry Sees "Gold Rush" Amid Uncertain Regulation  NPR
3. Researchers tease out genetic differences between cannabis strains  Phys.org
4. CBD-infused coffee is growing in popularity  CBS News
5. 4 CBD Stocks to Buy for Mainstream Marijuana Profits  Investorplace.com
6. View full coverage on Google News